DK3081560T3 - Taxanforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf - Google Patents
Taxanforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf Download PDFInfo
- Publication number
- DK3081560T3 DK3081560T3 DK14864217.6T DK14864217T DK3081560T3 DK 3081560 T3 DK3081560 T3 DK 3081560T3 DK 14864217 T DK14864217 T DK 14864217T DK 3081560 T3 DK3081560 T3 DK 3081560T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- taxane compounds
- taxane
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/87—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/76—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members
- C07C2603/80—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310595107.0A CN104650012A (zh) | 2013-11-22 | 2013-11-22 | 一种紫杉烷类化合物 |
| PCT/CN2014/091908 WO2015074605A1 (zh) | 2013-11-22 | 2014-11-21 | 一种紫杉烷类化合物、其制备方法和用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3081560T3 true DK3081560T3 (da) | 2021-06-21 |
Family
ID=53178984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14864217.6T DK3081560T3 (da) | 2013-11-22 | 2014-11-21 | Taxanforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10253007B2 (da) |
| EP (1) | EP3081560B1 (da) |
| JP (1) | JP6533794B2 (da) |
| KR (1) | KR102350002B1 (da) |
| CN (1) | CN104650012A (da) |
| AU (1) | AU2014352371B2 (da) |
| CA (1) | CA2931291C (da) |
| DK (1) | DK3081560T3 (da) |
| RU (1) | RU2686675C9 (da) |
| WO (1) | WO2015074605A1 (da) |
| ZA (1) | ZA201603682B (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110143934B (zh) * | 2018-08-29 | 2023-03-28 | 牡丹江师范学院 | 一种含氟紫杉烷类化合物及其制备方法与应用 |
| CN111196790B (zh) * | 2018-11-19 | 2023-02-21 | 江苏吉贝尔药业股份有限公司 | 新型紫杉烷类衍生物及其药物组合物和用途 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2679230B1 (fr) * | 1991-07-16 | 1993-11-19 | Rhone Poulenc Rorer Sa | Nouveaux derives d'analogues du taxol, leur preparation et les compositions qui les contiennent. |
| US6005138A (en) | 1991-09-23 | 1999-12-21 | Florida State University | Tricyclic taxanes having a butenyl substituted side-chain and pharmaceutical compositions containing them |
| US5721268A (en) * | 1991-09-23 | 1998-02-24 | Florida State University | C7 taxane derivatives and pharmaceutical compositions containing them |
| US5272171A (en) | 1992-02-13 | 1993-12-21 | Bristol-Myers Squibb Company | Phosphonooxy and carbonate derivatives of taxol |
| US5614549A (en) * | 1992-08-21 | 1997-03-25 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
| FR2696459B1 (fr) * | 1992-10-05 | 1994-11-25 | Rhone Poulenc Rorer Sa | Procédé de préparation de dérivés du taxane. |
| CA2109861C (en) * | 1992-12-04 | 1999-03-16 | Shu-Hui Chen | 6,7-modified paclitaxels |
| US5646176A (en) * | 1992-12-24 | 1997-07-08 | Bristol-Myers Squibb Company | Phosphonooxymethyl ethers of taxane derivatives |
| US6040466A (en) | 1996-03-25 | 2000-03-21 | Rhone Poulenc Rorer Sa | Taxoids, their preparation and pharmaceutical compositions containing them |
| CA2129288C (en) * | 1993-08-17 | 2000-05-16 | Jerzy Golik | Phosphonooxymethyl esters of taxane derivatives |
| IL127598A (en) * | 1994-01-28 | 2003-04-10 | Upjohn Co | Process for preparing isotaxol analogs |
| WO1996023779A1 (fr) * | 1995-02-02 | 1996-08-08 | Daiichi Pharmaceutical Co., Ltd. | Derives ethers |
| MA23823A1 (fr) * | 1995-03-27 | 1996-10-01 | Aventis Pharma Sa | Nouveaux taxoides, leur preparation et les compositions qui les contiennent |
| US5801191A (en) * | 1995-06-01 | 1998-09-01 | Biophysica Foundation | Taxoids |
| FR2745814B1 (fr) * | 1996-03-06 | 1998-04-03 | Rhone Poulenc Rorer Sa | Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent |
| ITMI20011734A1 (it) * | 2001-08-07 | 2003-02-07 | Indena Spa | Derivanti tassanici e procedimenti per la loro preparazione |
| CN1709864A (zh) * | 2005-07-08 | 2005-12-21 | 成都科杰高新技术发展有限公司 | 一种紫杉醇及其类似物侧链的合成方法 |
| WO2007076160A2 (en) * | 2005-12-28 | 2007-07-05 | Acidophil Llc | C-10 carbamates of taxanes |
| WO2010059916A2 (en) * | 2008-11-20 | 2010-05-27 | Dr. Reddy's Laboratories Ltd. | Preparation of docetaxel |
| DE112012004944T5 (de) | 2011-11-28 | 2014-12-11 | Fresenius Kabi Oncology Ltd. | Kristalline Formen von Cabazitaxel und deren Herstellungsverfahren |
-
2013
- 2013-11-22 CN CN201310595107.0A patent/CN104650012A/zh active Pending
-
2014
- 2014-11-21 CA CA2931291A patent/CA2931291C/en active Active
- 2014-11-21 KR KR1020167016717A patent/KR102350002B1/ko active IP Right Grant
- 2014-11-21 EP EP14864217.6A patent/EP3081560B1/en active Active
- 2014-11-21 WO PCT/CN2014/091908 patent/WO2015074605A1/zh active Application Filing
- 2014-11-21 AU AU2014352371A patent/AU2014352371B2/en active Active
- 2014-11-21 DK DK14864217.6T patent/DK3081560T3/da active
- 2014-11-21 JP JP2016554786A patent/JP6533794B2/ja active Active
- 2014-11-21 RU RU2016124639A patent/RU2686675C9/ru active
- 2014-11-21 US US15/038,264 patent/US10253007B2/en active Active
-
2016
- 2016-05-30 ZA ZA201603682A patent/ZA201603682B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3081560A1 (en) | 2016-10-19 |
| KR20160079135A (ko) | 2016-07-05 |
| CA2931291A1 (en) | 2015-05-28 |
| RU2016124639A (ru) | 2017-12-27 |
| ZA201603682B (en) | 2019-11-27 |
| CN104650012A (zh) | 2015-05-27 |
| RU2686675C1 (ru) | 2019-04-30 |
| AU2014352371A1 (en) | 2016-06-16 |
| US20160297784A1 (en) | 2016-10-13 |
| WO2015074605A1 (zh) | 2015-05-28 |
| JP2016539186A (ja) | 2016-12-15 |
| EP3081560A4 (en) | 2017-04-26 |
| EP3081560B1 (en) | 2021-03-24 |
| JP6533794B2 (ja) | 2019-06-19 |
| US10253007B2 (en) | 2019-04-09 |
| KR102350002B1 (ko) | 2022-01-10 |
| RU2686675C9 (ru) | 2019-09-26 |
| AU2014352371B2 (en) | 2018-10-18 |
| CA2931291C (en) | 2020-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2016001080A1 (es) | Benzamidas sustituidas para tratamiento de artrópodos. | |
| HK1215378A1 (zh) | 藥物組合物、治療方法及其用途 | |
| BR112015007494A2 (pt) | aparelho para tratamento dentário. | |
| DK3050848T3 (da) | Molekylesi, fremstillingsfremgangsmåde og anvendelse deraf | |
| DK2949625T3 (da) | Ammoniaksyntesefremgangsmåde | |
| BR112015019495A2 (pt) | aparelho de tratamento de vestuário. | |
| DK3204386T3 (da) | Substituerede aminopurinforbindelser, sammensætninger deraf og fremgangsmåder til behandling dermed | |
| DK3079719T3 (da) | ANTI-SIGLEC-8-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3063144T3 (da) | Antiparasitære og pesticid-isoxazolinforbindelser | |
| DK3030549T3 (da) | Pyridazinonforbindelser og anvendelser deraf | |
| HK1210806A1 (en) | Method for manufacturing immunocyte-containing composition, and cancer-treating composition | |
| BR112015019224A2 (pt) | aparelho, e método | |
| DK2964767T3 (da) | Toksingener og fremgangsmåder til anvendelse deraf | |
| DK2992104T3 (da) | Fremgangsmåde til ekspression | |
| DK2975030T3 (da) | Dihydropyridazin-3,5-dion-derivat | |
| DK3038656T3 (da) | Forbindelse af glycosaminoglycan, fremgangsmåde til fremstilling og anvendelse deraf | |
| ZA201604486B (en) | Timber treatment process | |
| DK2951552T3 (da) | Opfangningsanordning til engangsbrug | |
| DK2976101T3 (da) | Behandlingsfremgangsmåde | |
| ZA201603990B (en) | Taxane compound, and preparation method and use thereof | |
| ZA201600015B (en) | Anti-fibrogenic compounds, methods and uses thereof | |
| DK3181556T3 (da) | Mikromolekyleforbindelse, fremgangsmåde til syntese og anvendelse deraf | |
| DK3081560T3 (da) | Taxanforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| BR112015027749A2 (pt) | aparelho, e método | |
| DK3030597T3 (da) | Kædetermineret polymersammensætning, anvendelse deraf og fremgangsmåde til fremstilling deraf |